Tag: Amgen

Amgen Agreed to Buy Danish Biotech Nuevolution

amgen
Amgen has agreed to buy Danish biotech Nuevolution for 1.61bn krona ($167m), three years after forging a drug discovery alliance with the company. The board of Copenhagen-based, Sweden-listed Nuevo...

Amgen Announced Precision Medicine Collaboration in Oncology with Syapse

amgen
Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, announced a precision medicine collaboration in oncology. Und...

Amgen and Astellas Agreed to Pay $125M to Settle Medicare Kickback Claims

Amgen and Astellas’ U.S. branch have agreed to pay $124.75 million to resolve allegations that they each violated the False Claims Act by illegally paying the Medicare copays for their own products, t...

Astellas, Amgen to pay $125M After Probe in Co-Payment Scheme

astellas
Two drugmakers will pay nearly $125 million to resolve claims they used charities that help cover Medicare patients’ out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of ...

Amgen Set the List Price for the New Osteoporosis Drug

Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis drug at $1,825 a month, or $21,900 for a full 12-month course of injections. The U.S. Food and Drug Administration last ...

FDA Approved Amgen Osteoporosis Drug

The U.S. Food and Drug Administration approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are women with a history of os...

Legal Dispute between Novartis and Amgen

Novartis announced that there is a legal dispute with Amgen regarding the collaboration agreements in the field of migraine. On April 2, 2019, Amgen issued a notice of termination of its migraine coll...

GE Healthcare and Amgen in Digital Data Collaboration

GE Healthcare announces a digital data exchange collaboration program with Amgen, which will include advanced data analytics to increase the understanding of the relationship between raw material vari...

Sanofi and Regeneron Disagree Amgen to Keep Patents

Sanofi and Regeneron Pharmaceuticals Inc. announced they strongly disagree with certain aspects of jury verdict from the U.S. District Court for the District of Delaware. The jury upheld the validity ...

Amgen Keeps Patents Related to PCSK9 antibodies

Amgen announced that a Delaware jury delivered a verdict in Amgen's favor upholding the validity of two Amgen patents related to PCSK9 antibodies. These patents describe and claim antibodies, like Amg...

Abilita Bio and Amgen in Multi-Target Research Team

amgen
Abilita Bio, Inc. announced that it has entered into a multi-target research collaboration agreement with Amgen, a world leader in biotechnology. Under the terms of the agreement, Abilita Bio will lev...

CVS Added Teva and Lilly’s Drugs, Excluding Amgen’s

CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to its list of covered drugs, excluding a rival treatmen...

Expanded Indication from EC for Amgen’s Drug

Amgen announced that the European Commission (EC) has approved an expanded indication for BLINCYTO (blinatumomab) monotherapy to include adult patients with Philadelphia chromosome negative (Ph-) CD19...

Japan Approved Drug Rejected by FDA

Amgen’s osteoporosis bone-forming drug Evenity (romosozumab) has been approved in Japan, ahead of a crunch review by advisers to the US regulator later this month. Evenity could have been on the US...

Big Pharma Companies to Raise Drug Prices in January

Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry...

FDA Approved sBLA for Nplate® for Pediatric Patients

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Nplate® (romiplostim) for the treatment of pediatric patie...